CD32 expressing doublets in HIV infected gut-associated lymphoid are associated with a T follicular helper cell phenotype
File(s)s41385-019-0180-2.pdf (1.24 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Gut-associated lymphoid tissue (GALT) is a key location for the HIV reservoir. The observation that B-cell–T-cell doublets are enriched for CD32a (a low-affinity IgG receptor) in peripheral blood raises interesting questions, especially as these cells have been associated with HIV DNA in some studies. We sought to determine if similar doublets were present in GALT, the significance of these doublets, and their implications for the HIV reservoir. Given the importance of GALT as a reservoir for HIV, we looked for expression of CD32 on gut CD4 T cells and for evidence of doublets, and any relationship with HIV DNA in HIV + individuals initiated on antiretroviral therapy (ART) during primary HIV infection (PHI). Tonsil tissue was also available for one individual. As previously shown for blood, CD32high CD4 cells were mainly doublets of CD4 T cells and B cells, with T-cell expression of ICOS in tonsil and gut tissue. CD4 T cells associated with CD32 (compared with ‘CD32−' CD4 cells) had higher expression of follicular markers CXCR5, PD-1, ICOS, and Bcl-6 consistent with a T follicular helper (TFH) phenotype. There was a significant correlation between rectal HIV DNA levels and CD32 expression on TFH cells. Together, these data suggest that CD32high doublets are primarily composed of TFH cells, a subset known to be preferentially infected by HIV.
Date Issued
2019-09-01
Date Acceptance
2019-05-28
Citation
Mucosal Immunology, 2019, 12 (9), pp.1212-1219
ISSN
1933-0219
Publisher
Springer Nature [academic journals on nature.com]
Start Page
1212
End Page
1219
Journal / Book Title
Mucosal Immunology
Volume
12
Issue
9
Copyright Statement
© The Author(s) 2019. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Sponsor
MRC DCS
British HIV Association (BHIVA)
Merck Sharp & Dohme Ltd.
Medical Research Council (MRC)
Medical Research Council
Medical Research Council (MRC)
Identifier
https://www.nature.com/articles/s41385-019-0180-2
Grant Number
N/A
8101898808
MR/N001265/1
MR/N001265/1
MR/L00528X/1
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
PERSISTENCE
BLOOD
DNA
Adult
Aged
Antiretroviral Therapy, Highly Active
B-Lymphocytes
Biomarkers
CD4 Lymphocyte Count
Female
Gene Expression
HIV Infections
HIV-1
Humans
Immunophenotyping
Male
Middle Aged
Peyer's Patches
Receptors, IgG
T-Lymphocytes, Helper-Inducer
Viral Load
CHERUB investigators
Peyer's Patches
B-Lymphocytes
T-Lymphocytes, Helper-Inducer
Humans
HIV-1
HIV Infections
Receptors, IgG
CD4 Lymphocyte Count
Antiretroviral Therapy, Highly Active
Viral Load
Immunophenotyping
Gene Expression
Adult
Aged
Middle Aged
Female
Male
Biomarkers
Immunology
06 Biological Sciences
11 Medical and Health Sciences
Publication Status
Published
Article Number
952
Date Publish Online
2019-06-25